<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Hormonal Contraception</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Hormonal Contraception</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                14 Questions | 14 Total Marks | 24 min Duration | ~102.86 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 14 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 24 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 14</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Hormonal Contraception - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 14</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 14 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A 25-year-old female was diagnosed with endometriosis and was prescribed medication. She recently consulted her physician and an increase in hepatic enzymes and adverse lipid profile was noted. What do you think is the drug responsible for causing this?", "options": [{"label": "A", "text": "LNG IUD", "correct": false}, {"label": "B", "text": "OCP", "correct": true}, {"label": "C", "text": "GnRH analogues", "correct": false}, {"label": "D", "text": "Dienogest", "correct": false}], "correct_answer": "B. OCP", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>OCP OCP (Oral contraceptive pills) are associated with an increase in LDL and a decrease in HDL cholesterol. They are also responsible for increasing the hepatic enzymes.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Incorrect :  LNG IUD (levonorgestrel-releasing intrauterine device) causes side effects: Pelvic pain Ovarian cysts Intermenstrual bleeding headache Option: C. Incorrect : GnRH analogs cause hypo estrogenic side effects such as: Hot flashes Osteoporosis headaches Option: D. Incorrect Dienogest causes irregular bleeding and weight gain</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "All of the following are contraceptive implants except:", "options": [{"label": "A", "text": "Norplant", "correct": false}, {"label": "B", "text": "Implanon", "correct": false}, {"label": "C", "text": "Jadelle", "correct": false}, {"label": "D", "text": "Mesigyna", "correct": true}], "correct_answer": "D. Mesigyna", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Mesigyna Mesigyna is a once-a-month injectable contraceptive with a composition of 50 mg nor ethisterone and 5 mg estradiol valerate.</p>\n<p><strong>Highyeild:</strong></p><p>Non-oral hormonal contraceptives are: Hormone releasing IUCDs Injectable contraceptive - Progesterone only â€“ DMPA / NET EN Combined â€“cyclofem/mesigyna Injectable vaccine â€“ Anti-hCG Contraceptive implants: Norplant I Norplant II or Jadelle Implanon Vaginal ring</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. NORPLANT 1: Hormonal Implant Option: B. Implanon: Hormonal Implant Option: C. Jadelle: Hormonal Implant</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "All of the following mechanisms might account for a reduce-risk of upper genital tract infection in users of progestin-releasing IUDs, except:", "options": [{"label": "A", "text": "Reduced retrograde menstruation", "correct": false}, {"label": "B", "text": "Decreased ovulation", "correct": true}, {"label": "C", "text": "Thickened cervical mucus", "correct": false}, {"label": "D", "text": "Decidual changes in the endometrium", "correct": false}], "correct_answer": "B. Decreased ovulation", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Decreased ovulation Mechanisms account for a potentially reduced risk of upper-genital-tract infection in users of progestin-releasing IUDs . The effect of progestin on cervical mucus makes it thick and relatively impenetrable to bacteria. Since uterine bleeding is greatly decreased in users of the LNG-IUD (progestin-releasing IUD), any retrograde menstruation (which might seed the fallopian tubes with bacteria) should be reduced as well. Plus decidual changes in the endometrium may make it less susceptible to infection. In other words, progestin-releasing IUDs may mimic the protective effect of combined oral contraceptives and depot medroxyprogesterone acetate against upper-genital-tract infection. PID is common in non-hormonal IUCD-related bacterial infections are due to contamination of the endometrial cavity at the time of insertion . Actinomycosis infection is related to IUCD use. The most common side effect of IUCDs is increased vaginal bleeding.</p>\n<p><strong>Highyeild:</strong></p><p>IUDs: First-generation IUDs: These are inert or non-medicated devices. g. Lippeâ€™s loop. Second-generation IUDs : It consists of copper or silver-containing IUDs e.g. Cu T 200 , Cu T 380- Ag , Nova T , Multiload Cu 375 . Third generation IUDs ; This consists of hormone-releasing E.g. Progestasert , Mirena , LNG 20 . Commonly used IUD Lippe s Loop</p>\n<p><strong>Extraedge:</strong></p><p>Mechanism of Action of IUCD Non medicated IUCD Cu containing IUCD Progestin releasing IUCD â€¢ Act as a foreign body in the uterus and produces a sterile inflammation and tissue injury of a minor degree sufficient enough to be spermicidal .  therefore prevent both intra-uterine and ectopic pregnancy. â€¢ It provokes uterine contractility & increases tubal peristalsis. â€¢ Elute copper which bring about enzymatic and metabolic changes in the endometrial tissue & also produce changes in cervical mucus and endometrial secretions. â€¢ They cause decidualization with atrophy of endometrial glands and therefore inhibit implantation. â€¢ Alter cervical Mucus causing inhibition of sperm penetration and capacitation. â€¢ In 40% of cases ovulation is also inhibited. e.g. Lippeâ€™s loop. e.g.    Cu T 380- Ag, Nova T, Multiload 375 E.g. Progestasert,Mirena ,LNG 20</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "The progesterone component of OCP acts by:", "options": [{"label": "A", "text": "Preventing ovulation", "correct": false}, {"label": "B", "text": "Inhibiting implantation", "correct": false}, {"label": "C", "text": "Bringing about alterations in cervical mucus", "correct": false}, {"label": "D", "text": "All of the above", "correct": true}], "correct_answer": "D. All of the above", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>All of the above Actions of the progesterone component of combined oral contraceptives: Suppresses ovulation by its inhibitory action on the pituitary and the hypothalamus. This is predominantly achieved by estrogens but even by progesterone. Causes Atrophic changes in the endometrium and prevents nidation even if fertilization occurs. Acts on the cervical mucus , making it thick, and tenacious and impenetrable by sperms.</p>\n<p><strong>Extraedge:</strong></p><p>The third-generation progestogen has a higher affinity for progesterone receptors and has a role in inhibiting ovulation. The main function of progestogen in combined pills is, to counteract the undesirable effects of estrogen such as endometrial hyperplasia and heavy withdrawal bleeding.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Oral contraceptive pills decrease the incidence of all of the following conditions except:", "options": [{"label": "A", "text": "Salpingitis", "correct": false}, {"label": "B", "text": "Hepatic adenoma", "correct": true}, {"label": "C", "text": "Ovary CA", "correct": false}, {"label": "D", "text": "Fibroadenosis", "correct": false}], "correct_answer": "B. Hepatic adenoma", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Hepatic adenoma Hepatic adenoma is associated with the use of OCPs. The most common side effect of OCPs is Breakthrough Bleeding. >Tumors associated with OCP use Cervical cancer (adenoCA) Hepatic cancer Pituitary adenoma > OCPs provide protection against Ovarian tumors/cysts Uterine tumors and fibroid Benign breast disease Colon CA Non-contraceptive Benefits of OCPs - Cancers/cysts Uterine cancer Ovarian cancers Fibroid uterus (Progesterone only pills) Ovarian cysts Benign breast diseases The benign disease of the genital tract Endometriosis PID (here Salpingitis) Ectopic pregnancy (as it decreases the incidence of PID) They decrease ovulation thus, are helpful in Dysmenorrhea, premenstrual tension, and Mittelschmerz syndrome. By decreasing blood loss they are helpful in menorrhagia and polymenorrhea. Acne and hirsutism (especially those containing desogestrel) OCPs are also beneficial in: DUB Hormone therapy for hypothalamic amenorrhea Prevention of menstrual porphyria.</p>\n<p><strong>Highyeild:</strong></p><p>CONTRAINDICATIONS OF OCP : Absolute contraindications: 1) breast and genital cancer 2) Liver diseases 3)h/o thromboembolism 4)cardiac abnormalities 5)congenital hyperlipidemia 6) undiagnosed abnormal uterine bleeding Relative Contraindications: 1)Age over 40years, (if smoker >35 years ) 2)Hypertension 3)chronic renal disease 4)Epilepsy 5)Migraine 6)First 6 months of Breastfeeding 7) Diabetes Mellitus 8)Gallbladder disease 9)h/o infrequent bleeding or amenorrhea</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Hypokalemic paralysis is a side effect of:", "options": [{"label": "A", "text": "Gossypol", "correct": true}, {"label": "B", "text": "DMPA", "correct": false}, {"label": "C", "text": "Testosterone enanthate", "correct": false}, {"label": "D", "text": "Cyproterone acetate", "correct": false}], "correct_answer": "A. Gossypol", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Gossypol Gossypol It is a male contraceptive pill. Discovered in China from an extract of cottonseed. Mechanism of action inhibits spermatogenesis and decreases epididymal sperm motility. Side effect â€“ Hypokalemic paralysis in 1% of patients</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. DMPA Side Effects of DMPA Irregular bleeding/poor cycle control (Most common side effect). The occasional phase of amenorrhea Weight gain Prolonged infertility after its use (Ovulation begins 6-12 months after the last injection) therefore, is not suitable for women planning a pregnancy in the near future. Decreased bone mass (after prolonged use), so women should be advised to use calcium supplementation. Option: C. Testosterone enanthat It is an Injectable Esterified variant of Testosterone used in Male patients with low testosterone. And when used in high doses inhibits gonadotrophin secretion from the Pituitary gland. Option: D. Cyproterone acetate . It is an Antiandrogen. Given in PCOS associated Hyperandrogenic skin symptoms like Hirsutism .</p>\n<p><strong>Extraedge:</strong></p><p>Male hormonal contraceptives: Gossypol Testosterone enanthate injectable Testosterone buciclate injectable</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "True statement about Minipill is:", "options": [{"label": "A", "text": "Irregular vaginal bleeding may be a side effect", "correct": true}, {"label": "B", "text": "Used in with combination with oral contraceptive pills", "correct": false}, {"label": "C", "text": "Cannot be used in lactation", "correct": false}, {"label": "D", "text": "Prevents ectopic pregnancy", "correct": false}], "correct_answer": "A. Irregular vaginal bleeding may be a side effect", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Irregular vaginal bleeding may be a side effect</p>\n<p><strong>Highyeild:</strong></p><p>POP is devoid of any estrogen compound. It contains a very low dose of progestin in any one of the following form-Levonorgestrel 75 Âµg, norethisterone 350 Âµg, desogestrel 75 Âµg, lynestrenol 500 Âµg or norgestrel 30 ug. It has to be taken daily from the first day of the cycle. Mechanism of action: It works mainly by making cervical mucus thick and viscous, thereby preventing sperm penetration. The endometrium becomes atrophic, so blastocyst implantation is also hindered. In about 2 percent of cases, ovulation is inhibited and 50 percent women ovulate normally. How to prescribe a mini pill: The first pill has to be taken on the first day of the cycle and then continuously. It has to be taken regularly and at the same time of the day. There must be no break between the packs. Delay in intake for more than 3 hours, the woman should have missed the pill immediately and the next one as scheduled. Extra precaution has to be taken for the next 2 days (see above). Advantages: Side effects attributed to estrogen in the combined pill are totally eliminated No adverse effect on lactation and hence can be suitably prescribed in lactating women and as such it is often called a \"Lactation Pill\" Easy to take as there is no \"On and Off\" regime It may be prescribed in patients having (medical disorders) hypertension, fibroid, diabetes, epilepsy, smoking, and a history of thromboembolism Reduces the risk of PID and endometrial cancer. Disadvantages: There may be acne, mastalgia, headache, breakthrough bleeding, or at times amenorrhea in about 20-30 percent of cases All the side effects, attributed to progestins may be evident Simple cysts of the ovary may be seen, but they do not require any surgery The failure rate is about Contraindications: Pregnancy unexplained vaginal bleeding recent breast cancer arterial disease. thromboembolic disease. Main side effects of Minipill /progesterone-only pill: Irregular bleeding and amenorrhea</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option B : mini pills are Progesterone only pills Option C : mini pills can be used during lactation. Option D: Ectopic pregnancy is not prevented as effectively as intrauterine pregnancy. Although the overall incidence of ectopic pregnancy is not increased, When pregnancy occurs (with minipill use) the clinician must suspect that it is more likely to be ectopic. A previous ectopic pregnancy should not be regarded as a contraindication to the minipill.</p>\n<p><strong>Extraedge:</strong></p><p>How to Use In regular cycles Amenorrhea During lactation â€¢ Recent WHO recommendations suggest POP should be started within 1st five days of menstrual cycle without need of additional contraception (preferably 1st day). â€¢Start any time after being sure that there is no pregnancy (Additional protection or abstinence from sex being advised for the first 48 hours) â€¢ As per CDC guidelines it can be stated any time after delivery according to WHO it is started after 6 weeks >Traditional progesterone only pill should be taken every day without break and at the same time. Safety margin (3 hrs). If delay was for > 3 hrs - back method should be used. For newer desogestrel containing pill, a delay of ~12 hours can be accepted.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Characteristics of an ideal candidate for copper-T insertion include all of the following except:", "options": [{"label": "A", "text": "Has born at least one child", "correct": false}, {"label": "B", "text": "Is willing to check the IUD tail", "correct": false}, {"label": "C", "text": "Has a history of ectopic pregnancy", "correct": true}, {"label": "D", "text": "Has normal menstrual periods", "correct": false}], "correct_answer": "C. Has a history of ectopic pregnancy", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Has a history of ectopic pregnancy Options A, B, and D are ideal candidates for IUCD Ideal IUCD candidate as a woman. Who has no history of pelvic disease. Who has born at least one child Has normal menstrual periods Is willing to check IUCD tail Has access to follow-up and treatment of potential problems Is in a monogamous relationship.</p>\n<p><strong>Highyeild:</strong></p><p>Some important points from â€˜Leon Speroffâ€™ on patient selection for IUD. The risk factors for STIs (sexually transmitted infections) are the most important considerations Women who are on anticoagulants or have bleeding disorder or with heavy menstrual periods are not good candidates for copper IUCD but might benefit from progestin IUCD. Women who have abnormalities of the uterus like bicornuate uterus are not good candidates for IUD insertion. Immunosuppressed individuals should not use IUCD. Patients at risk for endocarditis should be treated with prophylactic antibiotics at the insertion and removal of IUCD. Cervical dysplasia is not a contraindication for the use of IUCD but in patients with cervical stenosis, it may be difficult to insert IUCD. Cu-containing IUCD can be the ideal choice for a woman with diabetes especially if vascular disease is present.</p>\n<p><strong>Extraedge:</strong></p><p>Contraindications for Insertion of IUCD: (1) Presence of pelvic infection current or within 3 months; (2) Undiagnosed genital tract bleeding; (3) Suspected pregnancy; (4) Distortion of the shape of the uterine cavity as in fibroid or congenital uterine-malformation; (5) Severe dysmenorrhea; (6) Past history of ectopic pregnancy; (7) Within 6 weeks following cesarean section; (8) STIs Current or within 3 months; (9) Trophoblastic disease; (10) Significant immunosuppression. Additionally for CuT are: (11) Wilson disease and (12) Copper allergy. For LNG-IUS are: (13) Hepatic tumor or hepatocellular disease (active); (14) Current breast cancer and (15) Severe arterial disease.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "An intrauterine pregnancy of approximately 10 weeks gestation is confirmed in a 30-year-old, gravida 5, para 4 woman with an IUD in place. The patient expresses a strong desire for the pregnancy to be continued. On examination, the string of the IUD is noted to be protruding from the cervical OS. The most appropriate course of action is to:", "options": [{"label": "A", "text": "Leave the IUD in place without any other treatment", "correct": false}, {"label": "B", "text": "Remove the IUD to decrease the risk of malformations", "correct": false}, {"label": "C", "text": "Remove the IUD to decrease the risk of infection", "correct": true}, {"label": "D", "text": "Terminate the pregnancy because of the high risk of malformations.", "correct": false}], "correct_answer": "C. Remove the IUD to decrease the risk of infection", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Remove the IUD to decrease the risk of infection Removing the IUD to decrease the risk of infection is the most appropriate course of action.</p>\n<p><strong>Highyeild:</strong></p><p>A woman with an IUCD in place , with amenorrhea should have a pregnancy test and pelvic examination . An intrauterine pregnancy can occur and continue successfully to term with an IUCD in place. Possibility 1-If an intrauterine pregnancy is diagnosed and IUCD strings are visible: IUCD should be removed as soon as possible in order to prevent septic abortion , premature rupture of membranes, and premature birth. Also, do an USG to know whether it is intrauterine or ectopic pregnancy. Possibility 2-If an intrauterine pregnancy is diagnosed and IUCD strings are not visible: An ultrasound e xamination should be performed to localize the IUCD and determine whether expulsion has occurred. If the IUCD is present there are 3 options for management. Therapeutic abortion If IUCD is not fundal in the location: ultrasound-guided intrauterine removal of IUCD. If IUCD is present in the fundus of the uterus : it should be left in place and pregnancy continued with the device left in place. If the pregnancy continues with the device in place, the patient should be warned of the symptoms of intrauterine infection like fever or flu-like symptoms, abdominal cramping, or bleeding. At the earliest sign of infection, high-dose intravenous antibiotic therapy should be given and the pregnancy evacuated promptly.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Not an appropriate option Option: B. Fetal malformations have not been reported to be increased with a device in place. Option: D. Fetal malformations have not been reported to be increased with a device in place.</p>\n<p><strong>Extraedge:</strong></p><p>Method of insertion of IUCD- No touch technique and withdrawal method. Insertion of Lippes loop by push technique Insertion of Multiload - Withdrawl technique without plunger</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 28-year-old P1L1 had Cu T inserted 2 years back, on examination, Cu T threads are not seen. USG shows Cu T partly in the abdominal cavity. Method of removal is:", "options": [{"label": "A", "text": "Hysteroscopy", "correct": false}, {"label": "B", "text": "No need for removal (wait and watch)", "correct": false}, {"label": "C", "text": "IUCD hook", "correct": false}, {"label": "D", "text": "Laparoscopy", "correct": true}], "correct_answer": "D. Laparoscopy", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Laparoscopy Laparoscopy is the most appropriate method of removal here. When IUCD enters the abdominal cavity (partly or completely), laparoscopy is the preferred modality for retrieval. Sometimes due to dense adhesions around the Cu T, a laparotomy may be required to remove it.</p>\n<p><strong>Highyeild:</strong></p><p>INDICATION FOR REMOVAL OF IUCD : Indications for removal: Persistent excessive regular or irregular uterine bleeding Flaring up of salpingitis Perforation of the uterus IUD has come out of place (partial expulsion) Pregnancy occurring with the device in situ Woman desirous of a baby Missing thread One year after menopause When the effective lifespan of the device is over. IUD removal is simple and can be done at any time. It is done by pulling the strings gently and slowly with forceps. METHOD OF REMOVAL OF IUD: Device inside the uterine cavity: It can be removed by any of the following methods mentioned below: (i) Especially designed blunt hook (Fig. 37.41). (ii) Artery forceps (Fig. 37.28) (iii) Uterine curette (Fig. 37.13) (iv) Hysteroscopically under direct vision (Fig. 29.6). Outside the uterus but inside the abdominal cavity: (i) Laparoscopy (ii) Laparotomy (rarely).</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. When Cu T is embedded within the uterine cavity , hysteroscopic removal is the method of choice. It is preferred over the IUCD hook. Hysteroscopy cannot visualize the Cu T that is in the abdominal cavity. Option: B. Copper in the abdominal cavity can cause an inflammatory reaction and can cause intestinal obstruction . Therefore it is necessary to remove it Option: C. IS NOT preferred method.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "The most common complication of IUCD is:", "options": [{"label": "A", "text": "Ectopic pregnancy", "correct": false}, {"label": "B", "text": "Bleeding", "correct": true}, {"label": "C", "text": "Backache", "correct": false}, {"label": "D", "text": "Cervical stenosis", "correct": false}], "correct_answer": "B. Bleeding", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Bleeding Bleeding most common side effect of IUCD. Less bleeding complaints with hormone-containing IUDs</p>\n<p><strong>Highyeild:</strong></p><p>Complication of IUCD The most common complication of IUCD is â€“ Bleeding Less bleeding complaints with hormone-containing IUDs Second most common complication- Pain Infectionâ€“Doxycycline 200 mg/azithromycin 500 mg should be given 1 hour before insertion to reduce infection. The most typical infection associated with Cu T use is actinomyces . Ectopic pregnancy-It is seen that ectopic pregnancy is 50% less likel y in women using IUCD than in women using no contraception. Partial or complete perforation â€” It is due to faulty technique of insertion Spontaneous expulsion â€”Usually occurs within a few months following insertion. Pain, abnormal uterine bleeding, and PID are the principal factors related to its discontinuation.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Ectopic pregnancy-It is seen that ectopic pregnancy is 50% less likel y in women using IUCD than in women using no Option: C. backache is not a specific side effect or complain Option: D. cervical stenosis is a contraindication of the insertion of IUDs</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Ideal contraceptive for lactating mother is:", "options": [{"label": "A", "text": "Barrier method", "correct": false}, {"label": "B", "text": "Combined OCP", "correct": false}, {"label": "C", "text": "Lactational amenorrhoea", "correct": false}, {"label": "D", "text": "Progesterone only pill", "correct": true}], "correct_answer": "D. Progesterone only pill", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Progesterone only pill Progesterone only pill. Mechanism of action: It works mainly by making cervical mucus thick and viscous , thereby preventing sperm penetration. The endometrium becomes atrophic, so blastocyst implantation is also hindered. POPs are safe with breastfeeding and very effective. They were mainly designed especially for lactating mothers.</p>\n<p><strong>Highyeild:</strong></p><p>In Breastfeeding Females For lactating mother s, contraceptives should be chosen in such a way that in addition to providing effective contraception, they do not adversely affect the success of lactation or the health of the infant. Barriers have a high failure rate of 4â€“14% and are not reliable for long-term control. As estrogens decrease the quality and quantity of milk , OCP pills are absolutely contraindicated in lactating mothers. POPs are safe with breastfeeding and very effective. They were mainly designed especially for lactating Progesterone only pill. Mechanism of action: It works mainly by making cervical mucus thick and viscous , thereby preventing sperm penetration. The endometrium becomes atrophic, so blastocyst implantation is also hindered.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option A: In a couple who are living separately in two cities and meet only, occasionally contraception of choice is a barrier method . Condoms are suitable for use in old age for couples who have frequent coitus, during lactation, during holidays, and subjects who cannot tolerate OCP, or IUCD. Option B: For newly married couples oral contraceptive pill is the method of choice provided there are no contraindications.It has many non-contraceptive benefits along with effective contraception but affects the quantity of milk. Barrier and Natural methods have a high failure rate. Option C: Lactation Amenorrhea Method (LAM) Excessive secretion of prolactin, which controls lactation, inhibits the pituitary. Prolactin inhibits luteinizing hormone (LH) but has no effect on follicle-stimulating hormone (FSH). However, it partially inhibits ovarian response to both of these gonadotropins. As a result, while the prolactin level remains high, the ovary produces little estrogen and no progesterone. Hence, ovulation and menstruation are affected. LAM is e ffective only till 6 months postpartum . Beyond this, it is not a reliable method. Even for 6 months, it is effective only if there is exclusive breastfeeding. If at any time in the first 6 months the menses starts, then it cannot be used as birth control.</p>\n<p><strong>Extraedge:</strong></p><p>Suited ideally for- Lactating women Sickle cell anemia (best contraceptive) Seizure disorder (raises seizure threshold)</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Contraceptive to be avoided in epilepsy:", "options": [{"label": "A", "text": "OCP", "correct": true}, {"label": "B", "text": "Condom", "correct": false}, {"label": "C", "text": "IUCD", "correct": false}, {"label": "D", "text": "Mirena", "correct": false}], "correct_answer": "A. OCP", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>OCP Epilepsy/seizure disorder is a relative contraindication for the use of OCPs as antiepileptic drugs like Phenytoin, carbamazepine, and phenobarbitone induce the synthesis of liver enzyme thereby reducing the plasma levels of ethinyl estradiol in women on combined pills, thereby increasing the chances of contraceptive failure. So in epilepsy OCPs should be avoided. Options B, C, andD - can be used in Epilepsy patients.</p>\n<p><strong>Highyeild:</strong></p><p>CONTRACEPTIVES IN EPILEPSY PATIENT Consideration should be given to methods that neither affect antiepileptic drug metabolism nor the methods affected by drugs. These include intrauterine contraception with copper IUD, or levonorgestrel-releasing IUD, long-acting progestin-only methods, barrier methods, and sterilization.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Drugs used for preventing preterm labor:", "options": [{"label": "A", "text": "Estrogen", "correct": false}, {"label": "B", "text": "Progesterone", "correct": true}, {"label": "C", "text": "Nifedipine", "correct": false}, {"label": "D", "text": "Ritodrine", "correct": false}], "correct_answer": "B. Progesterone", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Progesterone PRETERM LABOUR: The drug used for preventing preterm labor is progesterone. Progesterone is not a tocolytic. Therapeutic cervical cerclage can also be used for preventing preterm labor in pregnant females with gestational age Ë‚ 32 weeks and short a MgSO4, 4 g i/v loading dose followed by a maintenance dose of 1g/hr for 24 hours, reduces the risk of cerebral palsy in preterm infants . Thus, MgSO4 should be given to all females having preterm labor b etween 24-32 weeks.</p>\n<p><strong>Extraedge:</strong></p><p>CLASSIFICATION OF TOCOLYTICS B, adrenergic receptor agonist- -Terbutaline, Isoxsuprine, Retodrine Magnesium sulphate O Calcium channel blocker -Nifedipine and Nicardipine Oxytocin receptor antagonist Prostaglandin synthetase inhibitors -Indomethacin,Sulindac Nitric oxide -Nitroglycerine Halothane</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error("Questions data is empty or invalid");
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error("Failed to parse questions_json:", e);
            document.getElementById(